Micro-emulsion/submicro-emulsion in-situ gel preparation for eyes and its making method

An in-situ gel and submicron emulsion technology, which is applied in the direction of medical preparations containing active ingredients, pharmaceutical formulations, drug delivery, etc., can solve the inconvenience of industrial production and filling, does not have pseudoplastic deformation, and is not easy to apply drugs Uniform distribution and other problems, to overcome the rapid loss, easy and accurate control of the dosage, and prolong the residence time

Inactive Publication Date: 2007-09-05
SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
View PDF1 Cites 33 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Compared with the microemulsion in-situ gel, common gels have the following defects: ①Although common gels can increase the residence time of drugs in the eyes to exert their drug effects, there is also the phenomenon of evaporation of the drug aqueous solution, which requires frequent Drug administration can easily induce or aggravate lipid layer abnormalities; ②T

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] First, according to the composition of Example 1 given in Table 1 below, 1g VA palmitate, 1g vitamin E, 20g MCT, 10g soybean lecithin and 26g glycerin were mixed uniformly at 60°C, and then 500ml deionized water was added, Shear emulsification to obtain colostrum, and then use a high-pressure homogenizer to homogenize, and filter the prepared emulsion with a 0.45 μm microporous membrane; then dissolve 0.5 g of gellan gum in 400 ml of deionized water, stir and dissolve at 40 ° C, and Add it into the emulsion; then adjust the pH to 6.2 with a 0.3M triethanolamine solution; add 0.05g of the bacteriostatic agent benzalkonium chloride, make up to 1000ml with deionized water, and fill it.

Embodiment 2~4

[0053] Using the same preparation method as in Example 1, the microemulsion / submicroemulsion in-situ gel preparations of Examples 2-4 were prepared from the composition and process parameters given in Table 1.

[0054] Example 1

Embodiment 5~7

[0056] Using the same preparation method as in Example 1, the microemulsion / submicroemulsion in-situ gel preparations of Examples 5-7 were prepared from the composition and process parameters given in Table 2.

[0057] Example 5

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to view more

Abstract

An in-situ microemulsion / sub-microemulsion gel for treating eye disease is prepared from VA or its derivative, VE or its derivative, oil phase, emulsifier, thickening agent, isotonic regulator, antibacterial agent, pH regulator and purified water through shearing-high-pressure homogenizing process. It has high flowability. If it is dropped in eye, it can become hydrogel.

Description

technical field [0001] The present invention relates to an ophthalmic microemulsion / submicroemulsion in-situ gel preparation and a preparation method thereof, more specifically, to an ophthalmic microemulsion containing vitamin A or its derivatives and vitamin E or its derivatives / Submicroemulsion in situ gel preparation and preparation method thereof. Background technique [0002] Dry eye is one of the common diseases in ophthalmology clinic. The main symptoms are foreign body sensation, burning sensation and general eye discomfort. These discomforts are typically described as scratching, dry eyes, pain, grittiness, stinging or burning. [0003] The treatment of dry eye is usually to use artificial tears as an alternative treatment, that is, to use imitation artificial tears to form a new tear film with normal structure on the surface of the eyeball, so as to relieve the above-mentioned various discomfort symptoms. [0004] At present, artificial tears or drugs similar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/00A61K31/07A61K31/355A61P27/02
Inventor 甘勇甘莉马守伟朱春柳
Owner SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products